Search
Safinamide
go.drugbank.com/drugs/DB06654ApprovedInvestigationalSafinamide is for the treatment of parkinson's disease. It was approved in Europe in February 2015, and in the United States on March 21, 2017.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome, Cytochrome P-450 SubstratesProducts: XADAGO 100 MG TABLETASRECUBIERTAS CON PELÍCULA, XADAGO 50 MG TABLETAS RECUBIERTAS CON PELÍCULAHLA class I histocompatibility antigen, B alpha chain
go.drugbank.com/bio_entities/BE0004082TargetHumansAntigen-presenting major histocompatibility complex class I (MHCI) molecule. … Can bind different peptides containing allele-specific binding motifs, which are mainly defined by anchor residues at position 2 and 9 (PubMed:25808313, PubMed:29531227).
Polypeptides: HLA class I histocompatibility antigen, B alpha chainSynonyms: MHC class I antigen B*27, HLA class I histocompatibility antigen, B-27 alpha chainSodium iodide
go.drugbank.com/drugs/DB11119ApprovedInvestigationalSodium iodide is a source of iodine and can be administered as a supplement for total parenteral nutrition [L2065] but is more commonly used in veterinary medicine. … Radiolabelled compound, [DB09293], is used as a diagnostic tool to evaluate thyroid function and morphology.
Mixtures: FERTOMCIDINA U, FERTOMCIDINA UProducts: Micro I, ENJEKSİYONLUK ÇÖZELTİ İÇEREN FLAKON, 1 ADETFenoprofen
go.drugbank.com/drugs/DB00573ApprovedAn anti-inflammatory analgesic and antipyretic highly bound to plasma proteins. It is pharmacologically similar to aspirin, but causes less gastrointestinal bleeding.
Categories: Non COX-2 selective NSAIDS, Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)Synonyms: 2-(3-phenoxyphenyl)propionic acid, 2-(m-phenoxyphenyl)propionic acidDNA-directed RNA polymerase I subunit RPA1
go.drugbank.com/bio_entities/BE0012326TargetHumansCatalytic core component of RNA polymerase I (Pol I), a DNA-dependent RNA polymerase which synthesizes ribosomal RNA precursors using the four ribonucleoside triphosphates as substrates. … Forms Pol I active center together with the second largest subunit POLR1B/RPA2.
Polypeptides: DNA-directed RNA polymerase I subunit RPA1Synonyms: RNA polymerase I subunit A1, RNA polymerase I 194 kDa subunitInositol polyphosphate-4-phosphatase type I A
go.drugbank.com/bio_entities/BE0018619EnzymeHumansCatalyzes the hydrolysis of the 4-position phosphate of phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) (PubMed:15716355, PubMed:20463662). Also catalyzes inositol 1,3,4-trisphosphate and inositol 1,4-bisphosphate (By similarity). ...
Polypeptides: Inositol polyphosphate-4-phosphatase type I ASynonyms: Inositol polyphosphate 4-phosphatase type I, Type I inositol 3,4-bisphosphate 4-phosphatasePapaya
go.drugbank.com/drugs/DB10658ApprovedPapaya allergenic extract is used in allergenic testing.
Mixtures: Alka-pan TabletsCategories: Non-Standardized Food Allergenic ExtractFamciclovir
go.drugbank.com/drugs/DB00426ApprovedInvestigationalFamciclovir, marketed as Famvir by Novartis, is a guanine analogue used to treat herpes virus infections. It is most commonly used to treat herpes zoster (shingles). … Famciclovir is a prodrug of penciclovir with higher oral bioavailability.
Categories: Heterocyclic Compounds, 2-RingSynonyms: 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetateFamotidine
go.drugbank.com/drugs/DB00927ApprovedInvestigationalFamotidine is a competitive histamine-2 (H<sub>2</sub>) receptor antagonist that works to inhibit gastric acid secretion. … It is commonly used in gastrointestinal conditions related to acid secretion, such as gastric ulcers and gastroesophageal reflux disease (GERD), in adults and children.
Synonyms: N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide, 3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidineInternational brands: Sedanium-ROrlistat
go.drugbank.com/drugs/DB01083ApprovedInvestigational[L11130] This drug is a generally well-tolerated and effective weight-loss aid and is now available in both over-the-counter[L31963] and prescription preparations, depending on the dosage quantity. … It was approved by the FDA for use in combination with a reduced-calorie diet in 1999.
Categories: Miscellaneous GI Drugs, Cytochrome P-450 CYP3A InducersProducts: LIPOGRAS® 60 MG CAPSULA CON CONTENIDO LIQUIDO, LIPOGRAS® 120 MG CAPSULA DURA CON CONTENIDO LIQUIDO